EnglishFrenchGermanSpainItalianDutchRussianPortugueseJapaneseKoreanArabicChinese Simplified
If you like the site do not forget to Subscribe to our mailing list

Enter your E-mail address:

Wednesday, March 30, 2016

Mint can as anti-cancer drug!

Mint is one of those herbs most people associate with fresh breath or a soothing cup of tea. But researchers at India's Central Institute of Medicinal and Aromatic Plants (CIMAP) in Lucknow have been looking at it from a very different angle — as a potential weapon against cancer.

Their focus? A compound called L-Menthol, naturally found in the mint plant, which has shown a surprising ability to kill cancer cells and block their growth.

What Makes Menthol Stand Out

What makes this research particularly interesting is not just that menthol works against cancer cells — it's how it works. The compound appears to interfere with cell division, preventing cancer cells from multiplying and spreading to other organs. In laboratory studies, it has shown activity against colon cancer cells, and researchers believe it could have broader applications.

Menthol's potential isn't entirely new to science. Studies have looked at its effects on liver cancer, colon cancer, and even brain tumors. One intriguing area involves menthol-modified nanoparticles that can carry anti-cancer drugs across the blood-brain barrier — a major obstacle in treating brain tumors — achieving deeper penetration into tumor tissue than conventional formulations.

A Cost-Effective Alternative

One of the more practical arguments for exploring menthol as an anti-cancer agent is economics. Current cancer drugs are often extraordinarily expensive to produce. Paclitaxel, for instance, is derived from the bark of the European Yew tree — a slow-growing and limited resource. Menthol, by contrast, is cheap to produce, widely available, and already manufactured at scale for use in food, cosmetics, and pharmaceuticals.

That cost difference could matter enormously in making cancer treatments more accessible, especially in developing countries where high drug prices are a major barrier to care.

Research Is Still in Early Stages

It's worth being clear: this research is still primarily at the laboratory and preclinical stage. Menthol has shown genuine promise in cell studies and animal models, but it has not yet been through the rigorous clinical trials needed to confirm it as a human cancer treatment.

Scientists at the University of Salford in the UK have also been investigating a related compound, hoping to move toward testing on human cancer cells from breast and lung tissue. The path from a promising lab result to an approved drug is long and demanding — but the early signals are encouraging enough to keep researchers interested.

For now, mint remains your herb garden's most intriguing overachiever — and researchers are just beginning to understand what it might truly be capable of.


Source: Chemistry World

0 comments:

Post a Comment